Company: GHRS
Filing Date: 2025-07-29
Form Type: 20-F/A
Source: 0001140361-25-027850
Chunk: 266

Company: GH Research PLC
Filing Date: 2025-07-29
Form: 20-F/A
Chunk 266
---
5 |     | GH Research PLC 
 By:             | /s/ Velichka Valcheva |                         |
|:------|:--------------|:----|:----------------|:----------------------|:------------------------|
|       |               |     |                 | Name:                 | Velichka Valcheva       |
|       |               |     |                 | Title:                | Chief Executive Officer |

| By: | /s/ Julie Ryan |                         |
|     | Name:          | Julie Ryan              |
|     | Title:         | Vice President, Finance |

165 Table of Contents

INDEX TO FINANCIAL STATEMENTS

| Report of Independent Registered Public Accounting Firm (PCAOB ID:1366)                           
 Consolidated Statement of Comprehensive Loss for the years ended December 31, 2024, 2023 and 2022 
 Consolidated Statement of Financial Position as of December 31, 2024 and 2023                     | F-2 
 F-3 
 F-4 |
|:--------------------------------------------------------------------------------------------------|:----|
| Consolidated Statement of Changes in Equity for the years ended December 31, 2024, 2023, and 2022 | F-5 |
| Consolidated Statement of Cash Flows for the years ended December 31, 2024, 2023 and 2022         | F-6 |
| Notes to the Consolidated Financial Statements                                                    | F-7 |

F-1 Table of Contents

Report of Independent Registered Public Accounting Firm To theBoard of Directors and Shareholders of GH Research PLC Opinion on the Financial Statements We have audited the accompanying consolidated statements of financial position of GH Research PLC and its subsidiary(the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of comprehensive loss, changes in equity, and cash flows for each of the three years in the period ended December 31, 2024, including the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board. Basis for Opinion These consolidated financial statements are the responsibility of the Company’s management. Our